Boston Scientific Corporation
MX ˙ BMV ˙ FR0010424135
SecurityMX:BSX / Boston Scientific Corporation
InstitutionFifth Third Wealth Advisors LLC
Latest Disclosed Ownership53,099 shares
Latest Disclosed Value $ 3,331,962
Fifth Third Wealth Advisors LLC reports 5.38% increase in ownership of BSX / Boston Scientific Corporation

On April 17, 2026 - Fifth Third Wealth Advisors LLC filed a 13F-HR form disclosing ownership of 53,099 shares of Boston Scientific Corporation (MX:BSX) valued at $3,331,962 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 15, 2026 disclosing 50,387 shares of Boston Scientific Corporation. This represents a change in shares of 5.38% during the quarter.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-04-17 2026-03-31 13F BOSTON SCIENTIFIC COM 101137107 53,099 2,712 5.38 3,332 -30.66 0.1127
2026-01-15 2025-12-31 13F BOSTON SCIENTIFIC COM 101137107 50,387 -2,069 -3.94 4,804 -6.19 0.1686
2025-10-21 2025-09-30 13F BOSTON SCIENTIFIC COM 101137107 52,456 1,323 2.59 5,121 -6.76 0.1888
2025-07-25 2025-06-30 13F BOSTON SCIENTIFIC COM 101137107 51,133 13,818 37.03 5,492 45.91 0.2304
2025-04-08 2025-03-31 13F BOSTON SCIENTIFIC COM 101137107 37,315 5,566 17.53 3,764 32.77 0.1950
2025-01-14 2024-12-31 13F BOSTON SCIENTIFIC COM 101137107 31,749 3,204 11.22 2,836 18.52 0.1538
2024-11-07 2024-09-30 13F BOSTON SCIENTIFIC COM 101137107 28,545 -276 -0.96 2,392 7.80 0.1466
2024-07-23 2024-06-30 13F BOSTON SCIENTIFIC CORP COM COM 101137107 28,821 13,345 86.23 2,220 109.54 0.1683
2024-04-16 2024-03-31 13F BOSTON SCIENTIFIC CORP COM COM 101137107 15,476 -1,479 -8.72 1,060 8.06 0.1651
2024-01-08 2023-12-31 13F BOSTON SCIENTIFIC COM 101137107 16,955 -4,050 -19.28 980 -11.63 0.3183
2023-10-17 2023-09-30 13F BOSTON SCIENTIFIC COM 101137107 21,005 3,810 22.16 1,109 19.25 0.4478
2023-07-25 2023-06-30 13F BOSTON SCIENTIFIC COM 101137107 17,195 17,195 930 0.5996
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.